Drug Delivery and Translational Research

Springer Science+Business Media

Journal websitePeer review: Peer review
Evaluation status available after sign-in

About the journal

Drug Delivery and Translational Research is a journal published by Springer Science+Business Media in United States. It is listed in MEDLINE and PUBMED according to the sources read. Declared publication charge: 4,190 EUR. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.

Basic facts

Publisher
Springer Science+Business Media
ISSN
2190-393X · 2190-3948
Country
United States
Access
Not open access / not declared
Declared publication charge
4,190 EUR
Declared peer-review model
peer_review

Index listings

  • MEDLINE · 2015-01-01
  • PUBMED · 2011-02-01
Indexing
MEDLINE · PUBMED
APC
4,190 EUR
Declared review time (DOAJ)
—
Actual review time (measured)
107 days received→accepted — computed from PubMed (n=93)
Activity (OpenAlex)
Active — latest works 2026
PublishLens list status
Shown after sign-in
Counts for promotion at your university?
Choose your university and rank below ↓

Methodology signals (dated facts from their sources)

Details of the evaluation under the published methodology are shown to signed-in users (free).

Create a free account to view the evaluation

Journal profile

Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.

Works in OpenAlex

2176

Last recorded publication year

2026

Reported by OpenAlex in 1 of 3 sources (CC0 flags, not verified indexing)DOAJSciELOOpenAlex Core

h-index

89

i10-index

1283

From OpenAlex open data (CC0).

Editorial & policy6
Observed digital preservation (Keepers registry)— snapshot 2026-10-05
CLOCKSSPortico
Editorial board
Official page ↗
Norwegian register (HK-dir)— 2026
Level 1 — approved scholarly channel
Open references deposited at Crossref
96%
ORCID iDs in current deposits
74%
Enrolled in Crossref Similarity Check
✓
Deposits licence metadata at Crossref
✓
Identity & continuity3
Source type
journal
NLM unique ID (PubMed)
101540061
Society affiliations
Controlled Release Society
Classification(no data)

No data available to the platform for this group

No platform data for: Classification — absence is not a judgment about the journal.

Subject areas

  • Advanced Drug Delivery Systems
  • Advanced Drug Delivery Systems
  • Advanced Drug Delivery Systems
  • Nanoparticle-Based Drug Delivery
  • Advancements in Transdermal Drug Delivery
  • Advancements in Transdermal Drug Delivery
  • Advancements in Transdermal Drug Delivery
  • Drug Solubulity and Delivery Systems
Show all subjects (75)
  • Nanoparticle-Based Drug Delivery
  • Nanoparticle-Based Drug Delivery
  • RNA Interference and Gene Delivery
  • RNA Interference and Gene Delivery
  • RNA Interference and Gene Delivery
  • Drug Solubulity and Delivery Systems
  • Drug Solubulity and Delivery Systems
  • Hydrogels: synthesis, properties, applications
  • Inhalation and Respiratory Drug Delivery
  • Nanoplatforms for cancer theranostics
  • Nanoplatforms for cancer theranostics
  • Dermatology and Skin Diseases
  • Dermatology and Skin Diseases
  • Inhalation and Respiratory Drug Delivery
  • Inhalation and Respiratory Drug Delivery
  • Ocular Surface and Contact Lens
  • Ocular Surface and Contact Lens
  • Nanoplatforms for cancer theranostics
  • Intramuscular injections and effects
  • Advanced biosensing and bioanalysis techniques
  • Advanced biosensing and bioanalysis techniques
  • 3D Printing in Biomedical Research
  • 3D Printing in Biomedical Research
  • Lipid Membrane Structure and Behavior
  • Lipid Membrane Structure and Behavior
  • Wound Healing and Treatments
  • Electrospun Nanofibers in Biomedical Applications
  • Electrospun Nanofibers in Biomedical Applications
  • Wound Healing and Treatments
  • Immunotherapy and Immune Responses
  • Wound Healing and Treatments
  • Immunotherapy and Immune Responses
  • Electrospun Nanofibers in Biomedical Applications
  • Extracellular vesicles in disease
  • Tissue Engineering and Regenerative Medicine
  • Extracellular vesicles in disease
  • Graphene and Nanomaterials Applications
  • Dendrimers and Hyperbranched Polymers
  • Graphene and Nanomaterials Applications
  • Extracellular vesicles in disease
  • Bone Tissue Engineering Materials
  • Drug Transport and Resistance Mechanisms
  • Drug Transport and Resistance Mechanisms
  • Hydrogels: synthesis, properties, applications
  • Crystallization and Solubility Studies
  • Immunotherapy and Immune Responses
  • Barrier Structure and Function Studies
  • Drug Transport and Resistance Mechanisms
  • Hydrogels: synthesis, properties, applications
  • Bee Products Chemical Analysis
  • Bee Products Chemical Analysis
  • Toxin Mechanisms and Immunotoxins
  • Toxin Mechanisms and Immunotoxins
  • Curcumin's Biomedical Applications
  • Curcumin's Biomedical Applications
  • Bone Tissue Engineering Materials
  • Bone Tissue Engineering Materials
  • Surfactants and Colloidal Systems
  • Ultrasound and Hyperthermia Applications
  • Pharmacology and Nanomedicine Research
  • MicroRNA in disease regulation
  • MicroRNA in disease regulation
  • Protein purification and stability
  • Additive Manufacturing and 3D Printing Technologies
  • Protein purification and stability
  • Ocular Infections and Treatments
  • Cancer Immunotherapy and Biomarkers

Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.

Loading community confirmations…
How do we evaluate?Publisher of this journal? Appeal a derived assessment or request a factual correction

The journal's record in other sources:Web of Science MJLDOAJ

Everything shown here is produced automatically from named sources (DOAJ, OpenAlex, Crossref, PubMed, the Norwegian register) as of its capture date, with no human editing. Facts appear as recorded at the source; derived scores (PCI, PTD, PublishLens score) follow a published methodology. Not a judgement on the journal, not an official accreditation, not advice.

Wrong items are corrected automatically by re-reading the source (24 h for daily sources, 7 days for weekly ones) with a dated change log, and each item links to its source record. PublishLens-derived assessments are contested through the appeals mechanism (15 working days). Appeals · Indicator guide

Norwegian register data: Kanalregisteret (HK-dir, Norway) — CC BY 4.0 / NLOD — adapted: level extracted per year · OASPA member list — CC BY

Last automated source read: